(marketscreener.com) $15.5 million. It’s important to note that this figure doesn’t include any amount due to the purchase orders received by Casterra in the last few months and that Lavie Bio’s cash balance is set to increase by an additional $2.5 million in…

Conference call and webcast: today, November 15, 2023, 9:00 am ET
REHOVOT, Israel, Nov. 15, 2023 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aim…